메뉴 건너뛰기




Volumn 19, Issue 10, 2004, Pages 2216-2221

Breast cancer risk associated with being treated for infertility: Results from the French E3N cohort study

Author keywords

Breast cancer; Cohort study; Fertility drugs; Infertility; Risk factors

Indexed keywords

CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; CYCLOFENIL; FERTILITY PROMOTING AGENT; GCE; HUMAN MENOPAUSAL GONADOTROPIN; INDUCTOR;

EID: 6444235742     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/deh422     Document Type: Article
Times cited : (86)

References (26)
  • 4
    • 0036844001 scopus 로고    scopus 로고
    • Cumulative number of menstrual cycles and breast cancer risk: Results from the E3N cohort study of French women
    • Clavel-Chapelon F (2002) Cumulative number of menstrual cycles and breast cancer risk: results from the E3N cohort study of French women. Cancer Causes Control 13,831-838.
    • (2002) Cancer Causes Control , vol.13 , pp. 831-838
    • Clavel-Chapelon, F.1
  • 5
    • 0242390079 scopus 로고    scopus 로고
    • Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies
    • Collaborative Group on Hormonal Factors in Breast Cancer
    • Collaborative Group on Hormonal Factors in Breast Cancer (1996) Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Lancet 347,1713-1727.
    • (1996) Lancet , vol.347 , pp. 1713-1727
  • 6
    • 0030843969 scopus 로고    scopus 로고
    • Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer
    • Collaborative Group on Hormonal Factors in Breast Cancer
    • Collaborative Group on Hormonal Factors in Breast Cancer (1997) Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 350,1047-1059.
    • (1997) Lancet , vol.350 , pp. 1047-1059
  • 8
    • 0035988536 scopus 로고    scopus 로고
    • Cancer incidence following treatment for infertility at a clinic in the UK
    • Doyle P, Maconochie N, Beral V, Swerdlow AJ and Tan SL (2002) Cancer incidence following treatment for infertility at a clinic in the UK. Hum Reprod 17,2209-2213.
    • (2002) Hum. Reprod. , vol.17 , pp. 2209-2213
    • Doyle, P.1    Maconochie, N.2    Beral, V.3    Swerdlow, A.J.4    Tan, S.L.5
  • 9
    • 0025005851 scopus 로고
    • Infertility and breast cancer: A population-based case-control study
    • Gammon MD and Thompson DW (1990) Infertility and breast cancer: a population-based case-control study. Am J Epidemiol 132,708-716.
    • (1990) Am. J. Epidemiol. , vol.132 , pp. 708-716
    • Gammon, M.D.1    Thompson, D.W.2
  • 14
    • 0037380229 scopus 로고    scopus 로고
    • Infertility medication and the risk of breast cancer
    • Healy DL and Venn A (2003) Infertility medication and the risk of breast cancer. Fertil Steril 79,852-854.
    • (2003) Fertil. Steril. , vol.79 , pp. 852-854
    • Healy, D.L.1    Venn, A.2
  • 16
    • 0034016729 scopus 로고    scopus 로고
    • Cancer risk associated with subfertility and ovulation induction: A review
    • Klip H, Burger CW, Kenemans P and van Leeuwen FE (2000) Cancer risk associated with subfertility and ovulation induction: a review. Cancer Causes Control 11,319-344.
    • (2000) Cancer Causes Control , vol.11 , pp. 319-344
    • Klip, H.1    Burger, C.W.2    Kenemans, P.3    van Leeuwen, F.E.4
  • 18
    • 0027731037 scopus 로고
    • The influence of medical conditions associated with hormones on the risk of breast cancer
    • Moseson M, Koenig KL, Shore RE and Pasternack BS (1993) The influence of medical conditions associated with hormones on the risk of breast cancer. Int J Epidemiol 22,1000-1009.
    • (1993) Int. J. Epidemiol. , vol.22 , pp. 1000-1009
    • Moseson, M.1    Koenig, K.L.2    Shore, R.E.3    Pasternack, B.S.4
  • 19
    • 0032968322 scopus 로고    scopus 로고
    • Fertility drugs and the risk of breast and ovarian cancers: Results of a long-term follow-up study
    • Potashnik G, Lerner-Geva L, Genkin L, Chetrit A, Lunenfeld E and Porath A (1999) Fertility drugs and the risk of breast and ovarian cancers: results of a long-term follow-up study. Fertil Steril 71,853-859.
    • (1999) Fertil. Steril. , vol.71 , pp. 853-859
    • Potashnik, G.1    Lerner-Geva, L.2    Genkin, L.3    Chetrit, A.4    Lunenfeld, E.5    Porath, A.6
  • 23
    • 84990547781 scopus 로고
    • Rock JA and Schweppe KW (eds) Parthenon Publishing Group, Lancashire, UK
    • Schweppe KW (1988) In Rock JA and Schweppe KW (eds) Recent Advances in Management of Endometriosis. Parthenon Publishing Group, Lancashire, UK, pp. 13-30.
    • (1988) Recent Advances in Management of Endometriosis , pp. 13-30
    • Schweppe, K.W.1
  • 25
    • 0029112908 scopus 로고
    • Breast and ovarian cancer incidence after infertility and in vitro fertilisation
    • Venn A, Watson L, Lumley J, Giles G, King C and Healy D (1995) Breast and ovarian cancer incidence after infertility and in vitro fertilisation. Lancet 346,995-1000.
    • (1995) Lancet , vol.346 , pp. 995-1000
    • Venn, A.1    Watson, L.2    Lumley, J.3    Giles, G.4    King, C.5    Healy, D.6
  • 26
    • 0033530459 scopus 로고    scopus 로고
    • Risk of cancer after use of fertility drugs with in-vitro fertilisation
    • Venn A, Watson L, Bruinsma F, Giles G and Healy D (1999) Risk of cancer after use of fertility drugs with in-vitro fertilisation. Lancet 354, 1586-1590.
    • (1999) Lancet , vol.354 , pp. 1586-1590
    • Venn, A.1    Watson, L.2    Bruinsma, F.3    Giles, G.4    Healy, D.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.